BioSpace News Archive

Compression therapy is suggested immediately after an injury. Compression pumps and tapes are utilized to improve muscle health, increase blood circulation in the body and prevent coagulation of fluids in tissue space post accidental injuries.

Infrared spectroscopy (IR spectroscopy) is a spectroscopy that combines the infrared region of the electromagnetic spectrum, air with a bigger wavelength and decreased amplitude than visible light.

A kidney stone extraction balloon is a surgical device employed to enlarge ureteral structures before the kidney stone removal process, which is done by ureteroscopy.

Therma Bright Inc. currently trades on the OTC Pink Sheets under the symbol THRBF.

Median Technologies (Paris:ALMDT) today announces the appointment of Jean-Christophe Montigny as Chief Financial Officer.

Sanofi announces that its half-year financial report for the period ending June 30, 2021 is now available and has been filed with the French market regulator Autoritédes marchés financiers and submitted to the U.S. Securities and Exchange Commission under form 6-K.

Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has received FDA clearance for the latest version of its key science algorithm, Volpara Imaging Software (VIS 3.2).

Research presented at the Alzheimer’s Association International Conference® 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer’s disease pathology and symptoms.

Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced that its management team will present at the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021 at 10:30 a.m. Eastern Time.

ERYTECH Pharma (Nasdaq & Euronext: ERYP),a clinical-stage biopharmaceutical company, leader in red blood-cell based cancer therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL)patients who have developed hypersensitivity reactions to E. coli-derived pegylated asparaginase (PEG-ASNase).